AOK Niedersachsen. Die Gesundheitskasse.
Germany · 420 open tenders · 11 documented awards
Current tenders
Germany – Pharmaceuticals – Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for pharmaceuticals containing the active ingredient bosutinib (ATC code: L01EA04).
Deadline 27 Aug · 7 days left
Germany – Pharmaceuticals – Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for pharmaceuticals containing the active ingredient paliperidone – depot injection suspensions for three-month dosing only (ATC code: N05AX13).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive rebate agreement pursuant to § 130a paragraph 8 SGB V for medicinal products containing the active substance paliperidone – depot injection suspensions for three-month dosing only (ATC code: N05AX13).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a(8) SGB V for medicinal products containing the active substance trastuzumab (ATC: L01FD01).
Deadline 27 Aug · 7 days left
Germany – Pharmaceuticals – Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for pharmaceuticals containing the active ingredient adalimumab (ATC code: L04AB04).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active substance bosutinib (ATC code: L01EA04).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active substance goserelin (ATC code: L02AE03).
Deadline 27 Aug · 7 days left
Germany – Pharmaceuticals – Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for pharmaceuticals containing the active ingredient Trastuzumab (ATC: L01FD01).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active ingredient adalimumab (ATC code: L04AB04).
Deadline 27 Aug · 7 days left
Germany – Pharmaceuticals – Conclusion of a non-exclusive rebate agreement pursuant to § 130a (8) SGB V for pharmaceuticals containing the active substance Goserelin (ATC code: L02AE03).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive rebate agreement pursuant to § 130a (8) SGB V for medicinal products containing the active ingredient combination of drospirenone and ethinylestradiol (ATC code: G03AA12).
Deadline 27 Aug · 7 days left
Germany – Pharmaceuticals – Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for pharmaceuticals with the active ingredient combination of drospirenone and ethinylestradiol (ATC code: G03AA12).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive rebate agreement pursuant to § 130a Para. 8 SGB V for medicinal products containing the active ingredient goserelin (ATC code: L02AE03).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active substance bosutinib (ATC code: L01EA04).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a(8) SGB V for medicinal products containing the active ingredient adalimumab (ATC code: L04AB04).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active substance paliperidone - depot injection suspensions for three-month dosing only (ATC code: N05AX13).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products with the active ingredient combination of drospirenone and ethinylestradiol (ATC code: G03AA12).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active ingredient trastuzumab (ATC: L01FD01).
Deadline 27 Aug · 7 days left
Conclusion of a non-exclusive rebate agreement pursuant to § 130a (8) SGB V for medicinal products containing the active substance omalizumab (ATC code: R03DX05).
Deadline 27 Sept · 38 days left
Conclusion of a non-exclusive rebate agreement pursuant to § 130a (8) SGB V for medicinal products containing the active substance tiotropium bromide (ATC code: R03BB04) in the pharmaceutical form of inhalation solution.
Deadline 27 Sept · 38 days left
Germany – Pharmaceuticals – Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for pharmaceuticals containing the active ingredient estradiol (ATC code: G03CD03, G03CA03).
Deadline 27 Sept · 38 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a (8) SGB V for medicinal products containing the active substance testosterone (ATC: G03BA03).
Deadline 27 Sept · 38 days left
Germany – Pharmaceuticals – Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for pharmaceuticals containing the active substance omalizumab (ATC code: R03DX05).
Deadline 27 Sept · 38 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active substance estriol (ATC code: G03CA04, G03CD01).
Deadline 27 Sept · 38 days left
Germany – Pharmaceuticals – Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for pharmaceuticals containing the active ingredient estriol (ATC code: G03CA04, G03CD01).
Deadline 27 Sept · 38 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a (8) SGB V for medicinal products containing the active ingredient filgrastim (ATC code: L03AA02).
Deadline 27 Sept · 38 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a (8) SGB V for pharmaceuticals containing the active ingredient vildagliptin (ATC code: A10BH02).
Deadline 27 Sept · 38 days left
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active ingredient estradiol (ATC code: G03CD03, G03CA03).
Deadline 27 Sept · 38 days left
Germany – Pharmaceuticals – Conclusion of a non-exclusive rebate agreement pursuant to § 130a (8) SGB V for pharmaceuticals containing the active ingredient filgrastim (ATC code: L03AA02).
Deadline 27 Sept · 38 days left
Germany – Pharmaceuticals – Conclusion of a non-exclusive rebate agreement pursuant to § 130a(8) SGB V for pharmaceuticals containing the active substance vildagliptin (ATC code: A10BH02).
Deadline 27 Sept · 38 days left
Purchasing rhythm
Awards per year — who knows the rhythm prepares before the notice appears.
2022127
2023123
2024192
2025295
2026151
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Horn GmbH · Stutensee | 3 | 2025 |
| AbZ Pharma GmbH · Ulm | 1 | 2022 |
| amasol GmbH | 1 | 2026 |
| Binect GmbH · Weiterstadt | 1 | 2026 |
| COMRAMO AG · Hannover | 1 | 2026 |
| DIGOTEX GmbH · Niederfischbach | 1 | 2026 |
| Klinikverbund Landkreis Diepholz gGmbH | 1 | 2025 |
| Stackfield GmbH · München | 1 | 2026 |
| tde - trans data elektronik GmbH · Dortmund | 1 | 2024 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.